Related Experiment Videos
6-Aminonicotinamide-induced eye defects in rats
Morphologie Et Embryologie
|October 1, 1978
Summary
6-aminonicotinamide (6-AN) causes developmental eye defects in rat embryos, demonstrating phase specificity and acting through multiple teratogenic pathways. Recovery may play a role in mitigating some chemically induced developmental anomalies.
Area of Science:
- Developmental Biology
- Teratology
- Toxicology
Background:
- 6-aminonicotinamide (6-AN) is a known teratogen.
- Understanding the mechanisms of chemically induced developmental anomalies is crucial for prenatal health.
- Previous research suggests multiple teratogenic pathways exist.
Purpose of the Study:
- To investigate the pathological changes and structural anomalies induced by 6-AN in the developing rat eye.
- To determine the phase specificity of 6-AN teratogenicity.
- To explore the potential teratogenic pathways and distribution of chemically induced defects.
Main Methods:
- Administration of 6-AN to pregnant Wistar and hooded randombred rats via intraperitoneal and intraamniotic routes at specific gestational days.
- Macroscopic and microscopic examination of embryos and fetuses from day 10 to 20 of gestation.
- Comparison with control groups receiving distilled water.
Main Results:
- 6-AN induced distinct pathological changes and structural anomalies in the developing rat eye.
- The observed teratogenic effects exhibited clear phase specificity.
- Evidence suggests 6-AN acts through multiple teratogenic pathways.
Conclusions:
- 6-AN is a potent teratogen affecting eye development in a stage-specific manner.
- The findings support the hypothesis that teratogens can act through distinct pathways.
- Recovery mechanisms may influence the outcome of chemically induced developmental defects.